Latest / The Dales Report | Trade to Black
Curaleaf Launches Hostile Bid for Aurora Cannabis | TDR Cannabis in 5
The proposed deal combines Curaleaf’s scale, U.S. distribution network, and cash flow with Aurora’s premium genetics, EU-GMP certified production facilities, and established European market share in countries like Germany, Poland, and the UK. While Aurora boasts healthy gross margins near 57%, the company continues to burn cash, losing roughly $7 million per quarter, with SG&A costs exceeding 50% compared to Curaleaf’s 29%. Jordan believes integrating Aurora into Curaleaf’s cost structure could unlock $40-50 million in immediate profitability.The offer includes a mix of cash and Curaleaf…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.